Industrifonden is proud to announce that Peter Wolpert has been appointed its new CEO. Peter has extensive experience developing and taking life science and tech companies to market. He will take up the helm at Industrifonden in March 2022. He succeeds David Sonnek, who joins Navigare Ventures.

Peter Wolpert has over 20 years of experience in company development as CEO, strategy consultant and board member. He founded the pharmaceutical company Moberg Pharma AB (publ) in 2006, which reached close to half a billion SEK in revenue worldwide before its commercial portfolio was divested in 2019. Peter’s portfolio of successful ventures includes companies that have been publicly listed, entered partnerships or been acquired by leading investors and industrial players in the US, Europe and Asia. Peter has been based in the US for the past few years, and is currently chairman of the board of Moberg Pharma AB (publ) and advisor to A3P Biomedical AB and OncoZenge AB (publ). He has been advisor to a number of smaller companies, including Appeal Software Solutions which was sold to BEA (today Oracle) in 2002, and previously worked as a strategy consultant at McKinsey & Co. Peter has an MSc in Engineering Physics from the Royal Institute of Technology (KTH) and an MSc in Economics from the Stockholm School of Economics.

“We are very pleased to have recruited Peter Wolpert as the new CEO of Industrifonden. Peter’s experience of taking companies from innovation to commercialization, and his passion for research and technology development will be a great asset to the fund. Peter is also a strong leader and team builder with extensive experience in both corporate financing and commercial negotiations. Together with Industrifonden’s experienced analyst and investment team, Peter will continue our strategic journey to make Sweden smarter by investing early in growth companies where Industrifonden can make a difference”, says Industrifonden chairman Birgitta Stymne Göransson.

“Industrifonden has an important role to play by investing in the best innovative ventures and supporting them to mature into successful global businesses. Building a successful company from a pioneering innovation requires deep technology insight, willingness to take risk and perseverance. I am excited to work together with the team at Industrifonden, talented entrepreneurs and investment partners to make Sweden stronger”, says incoming CEO Peter Wolpert.

Industrifonden is an independent foundation with 6 billion SEK under management that invests in early- and growth-stage companies in deep tech, life science and transformative tech. Initial investments are typically 10–50 million SEK, with the capacity to reinvest further during the holding period. Industrifonden’s 40 years of experience in scaling and growth includes investments such as Funnel, EnginZyme, Asgard Therapeutics, Arcam, Oatly and CellaVision. Industrifonden is constantly looking for the most transformative venture opportunities in Sweden; those with a potential to provide meaningful improvements to our lives, industries, and to the society.

The board has appointed Per Anell, Senior Investment Director at Industrifonden, as acting CEO until Peter Wolpert takes office in March 2022.

If you’re curious to learn more, see this interview with Peter Wolpert in DI Digital today.

Categories: People

About the Author